Infusion Catheter Market By Product Type (Central Venous Catheters, Peripheral Venous Catheters, Midline Catheters), By Application (Chemotherapy, Infectious Disease Treatment, Pain Management, Nutritional Support), By End-User (Hospitals, Ambulatory Surgical Centers, Clinics, Homecare Settings), By Material (Polyurethane, Silicone), and By Region; Global Insights & Forecast (2023 – 2030)

As per Intent Market Research, the Infusion Catheter Market was valued at USD 2.2 Billion in 2024-e and will surpass USD 4.0 Billion by 2030; growing at a CAGR of 10.9% during 2025-2030.

The infusion catheter market is experiencing significant growth, driven by advancements in medical technology, rising prevalence of chronic diseases, and the increasing adoption of minimally invasive procedures. These devices are essential for administering medications, fluids, and nutrients directly into the bloodstream, making them indispensable in various medical applications. The market's evolution is shaped by innovation, expanding healthcare infrastructure, and the growing emphasis on patient-centric care.

Central Venous Catheters (CVCs) Are the Largest Subsegment Owing to Versatile Applications

Central Venous Catheters (CVCs) dominate the infusion catheter market due to their ability to deliver medications, nutrients, and fluids directly into large veins, making them critical in complex medical scenarios. These catheters are widely used in chemotherapy, dialysis, and intensive care, where high precision and reliable vascular access are essential.

The increasing prevalence of cancer and kidney diseases has further boosted the demand for CVCs, as they enable prolonged treatments with minimal patient discomfort. Hospitals remain the largest adopters of CVCs, driven by their widespread use in critical care units and surgical interventions. Continuous technological advancements, such as antimicrobial coatings, are also enhancing the safety and efficacy of these devices.

Chemotherapy Segment Is the Largest Owing to Rising Cancer Cases

Among applications, chemotherapy stands out as the largest subsegment due to the growing incidence of cancer worldwide. Infusion catheters are vital in administering chemotherapy drugs directly into the bloodstream, ensuring targeted treatment and minimizing side effects. The increasing adoption of advanced catheter technologies, such as peripherally inserted central catheters (PICCs), is enhancing patient outcomes and reducing complications.

Governments and healthcare providers are heavily investing in cancer treatment facilities, which is further driving the demand for infusion catheters in chemotherapy. With cancer becoming a major global health concern, this segment is poised for sustained growth in the coming years.

Homecare Settings Are the Fastest Growing Subsegment Owing to Patient-Centric Care

In the end-user segment, homecare settings are witnessing the fastest growth, driven by the increasing shift towards outpatient care and patient-centric healthcare delivery models. Infusion catheters used in homecare allow patients to receive treatments such as nutritional support and antibiotics without hospital visits, improving convenience and reducing healthcare costs.

This trend is supported by the rising geriatric population and the growing prevalence of chronic conditions that require long-term care. Moreover, advancements in portable infusion devices are making it easier for patients to manage their treatments at home, boosting the adoption of infusion catheters in this setting.

Polyurethane Catheters Lead the Market Owing to Flexibility and Safety

Polyurethane catheters dominate the material segment due to their superior flexibility, durability, and compatibility with a wide range of infusion applications. These catheters provide a balance between strength and softness, reducing the risk of vein irritation or damage. They are extensively used in both short-term and long-term treatments, making them a preferred choice in hospitals and clinics.

The biocompatibility and cost-effectiveness of polyurethane catheters have further fueled their adoption, especially in emerging markets where affordability is a critical factor. Manufacturers are continuously innovating to improve the safety and performance of these devices, ensuring their continued dominance in the market.

Asia-Pacific Is the Fastest Growing Region Owing to Expanding Healthcare Infrastructure

Asia-Pacific is emerging as the fastest-growing region in the infusion catheter market, driven by rapid economic growth, increasing healthcare investments, and a rising burden of chronic diseases. Countries such as China and India are witnessing significant advancements in healthcare infrastructure, along with government initiatives to improve access to medical treatments.

The region’s growing geriatric population and increasing adoption of advanced medical technologies are also contributing to the market's expansion. Additionally, the cost-effectiveness of treatment options and the presence of a large patient pool make Asia-Pacific a lucrative market for infusion catheter manufacturers.

Competitive Landscape and Leading Companies

The infusion catheter market is highly competitive, with leading players such as Medtronic, BD, Abbott Laboratories, and Boston Scientific driving innovation through continuous R&D investments. These companies focus on developing advanced catheter technologies, such as antimicrobial coatings and biocompatible materials, to enhance patient safety and outcomes.

Emerging players are also entering the market, offering cost-effective solutions to cater to the needs of developing regions. Strategic initiatives such as mergers, acquisitions, and collaborations are shaping the competitive landscape, enabling companies to expand their product portfolios and geographical presence. This dynamic environment ensures that the infusion catheter market remains poised for sustained growth and innovation.

Recent Developments:

• Medtronic Launches New Infusion Catheter – Medtronic announced the launch of a new central venous catheter designed for enhanced safety and ease of use in critical care settings.
• Teleflex Acquires Neovasc's Infusion Catheter Assets – Teleflex, a leading medical device company, acquired the infusion catheter assets of Neovasc to expand its product portfolio in the cardiovascular space.
• Smiths Medical Receives FDA Approval for New Infusion Catheter – Smiths Medical’s new peripherally inserted central catheter (PICC) received FDA approval, offering improved durability and ease of insertion.
• Fresenius Kabi Expands Infusion Catheter Offerings – Fresenius Kabi announced the expansion of its infusion catheter portfolio with the introduction of a new catheter specifically designed for pediatric patients.
• AngioDynamics Launches Specialty Infusion Catheter – AngioDynamics launched a specialty infusion catheter designed for precise drug delivery in oncology treatments, enhancing the efficacy of chemotherapy regimens.

List of Leading Companies:

• B. Braun Melsungen AG
• Teleflex Incorporated
• Smiths Medical
• Medtronic
• Abbott Laboratories
• Johnson & Johnson
• Cook Medical
• Cardinal Health
• Fresenius Kabi
• Terumo Corporation
• AngioDynamics
• Halyard Health
• Vygon
• ICU Medical
• Mindray

Report Scope: